Supplement Recall: A&P Creations X10 Natural Enhancement
Announced 2026-10-14 · FDA
The FDA is recalling A&P Creations X10 Natural Enhancement Supplement because it contains undeclared sildenafil and tadalafil. About 3,116 bottles were distributed nationwide in the United States. The recall covers Lot biQ-f001-06-25 (expiry 05/06/2027) and Lot biQ-003-01-26 (expiry 01/01/28).
| Brand | A&P CREATIONS |
|---|---|
| Product | biQ-FEL, 16.9 fl oz (500 mL), 17 servings per bottle, Manufactured by ALMENAT SAS AV 39 OESTE No 10 OESTE-18 CALI VALLE INDUSTRIA COLOMBIANA; Distributed by: Biofel |
| Reason | Product contains undeclared Sildenafil and Tadalafil. |
| Severity | critical |
| Units affected | 1283 |
| Distribution | Distributed nationwide (US). |
| Agency | FDA |
WHAT YOU SHOULD DO
- Stop using the product immediately and set it aside.
- Check your bottles for the recall lots and expiry dates; discard or return them per retailer or recall instructions.
- If you have taken this product and have health concerns, contact your healthcare provider.
- Monitor FDA updates for additional guidance and available remedies.
How to identify the recalled item
| Lot / date codes | Lot # biQ-f001-06-25, Expiry: 05/06/2027; Lot # biQ-003-01-26, Expiry: 01/01/28 |
|---|---|
| Lot / date codes | Lot # F090824LN16, Expiry: 8/2026; Lot # F170325LN19, Expiry: 03/2027; Lot # 300326LN28, Expiry: 03/2028. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other supplement recalls
- Supplement Recall: Vital Nutrients Aller-C · 2026-04-15
- Supplement Recall: Sato Energy & Health with Vitamins · 2026-02-04
- Supplement Recall: Herbs Forever Gastro Care · 2026-01-21
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.